Jeff Yass’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,000
Closed -$8.8K 13308
2024
Q2
$8.8K Sell
10,000
-23,000
-70% -$47.4K ﹤0.01% 11786
2024
Q1
$135K Buy
+33,000
New +$148K ﹤0.01% 10994
2023
Q4
Sell
-19,800
Closed -$102K 13513
2023
Q3
$102K Sell
19,800
-3,400
-15% -$16K ﹤0.01% 10904
2023
Q2
$112K Buy
+23,200
New +$80.3K ﹤0.01% 10875

Jeff Yass's AUGX Position: Q4 2024 in Review

Jeff Yass sold out of Augmedix, Inc. Common Stock (AUGX) in Q4 2024, closing a stake of 130,434 shares — an estimated $307K sold.

Jeff Yass first reported a position in AUGX in Q2 2023 and held it in 6 quarters. The position peaked at $1.08M in Q1 2024. 0 funds tracked by Wall St. Rank hold AUGX as of Q4 2024.

  • Jeff Yass reported no remaining Augmedix, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Jeff Yass sold 130,434 Augmedix, Inc. Common Stock shares in Q4 2024, an estimated $307K.
  • Jeff Yass first reported a position in Augmedix, Inc. Common Stock in Q2 2023 and held it in 6 quarters.
  • Jeff Yass's Augmedix, Inc. Common Stock position peaked at $1.08M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q4 2024.

Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.